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Nephron-sparing surgery (NSS) is the treatment of choice 
for cT1 kidney tumors as it provides similar oncological 
safety in comparison with radical nephrectomy with the 
advantage of preservation of renal function and improved 
overall survival (1). In the minimally invasive era, robot-
assisted partial nephrectomy (RAPN) has gained great 
popularity, when compared with open or laparoscopic-
assisted NSS, as it offers similar oncological results with 
better perioperative outcomes (2,3). Furthermore, the 
robotic approach offers to surgeon three-dimensional (3-D) 
visualization of the operative field, improved dexterity 
as well as precision of movements resulting in a shorter 
learning curve. RAPN has become the preferred approach 
over laparoscopic-assisted partial nephrectomy even for 
large and complicated tumors.
The article by Buffi et al., which was published in a recent 
issue of European Urology, explored the outcomes of RAPN 
in patients with complex renal tumors (PADUA score ≥10) 
and compared the observed outcomes between patients 
with increasing complexity. The authors, also, described 
the use of the latest induced technologies in RAPN, such as 
the TilePro technology, near-infrared fluorescence (NIRF) 
imaging, and hyperaccuracy 3-D (HA3D) reconstruction. 
In their retrospective analysis, they included 225 patients, 
and the surgeries were performed in four different tertiary 
centers over a period of 7 years. Within the cohort, 111 
patients had a PADUA score of 10, 85 patients had a 
PADUA score of 11, while 45 and 14 patients had a PADUA 
score of 12 and 13, respectively.
The authors have correctly identified the lack of large, 
multi-institutional studies in the literature assessing the 
outcomes of RAPN in patients with highly complex 
tumors and attempted to elucidate this specific field. The 
primary outcome of this study was the reporting of the 
outcomes of RAPN in the selected patient population. 
The approach was transperitoneal in 186 (72.9%) patients 
and retroperitoneal in 69 patients (27.1%) and the median 
operative time was 159 (IQR: 120–210) minutes. The 
type of ischemia was main artery clamping to the majority 
of patients, while selective clamping and zero ischemia 
were also used (70.4% vs. 16.5% vs. 5.1%, respectively). A 
median estimated blood loss of 150 (IQR: 100–250) mL 
and a median warm ischemia time (WIT) of 18 (IQR: 
15–23) were noted. Authors reported a Clavien-Dindo >2 
complication in 13 (5.1%) patients, while positive surgical 
margins (PSMs) were observed in 4 patients (1.9% of 
patients with malignant histology), and the conversions to 
open surgery and radical nephrectomy were 4 (1.6%) and 5 
(1.9%), respectively.
An additional outcome was the achievement of optimal 
surgical outcomes, which was defined according to the 
Margin Ischemia and Complication (MIC) binary system 
(absence of Clavien-Dindo >2 complications, WIT <20 min, 
and absence of PSMs) (4). Overall, optimal surgical 
outcomes were achieved in 158 (62%) patients. Regarding 
tumors with the highest complexity, the results showed 
a significantly lower rate of MIC achievement in tumors 
of PADUA score 12–13 compared to tumors of PADUA 
score 10 and PADUA score 11, 40.7%, 68.5%, and 68.2%, 
respectively (P=0.001). Independent predictors of not 
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achieving MIC in multivariate analysis were PADUA score 
12–13 and male gender. These results are in line with 
previous studies; in a large single institutional series, the 
rate of optimal surgical outcomes was decreasing through 
the patients as the PADUA complexity score was increasing, 
from 65.3% and 56.9% for patients with low and 
intermediate complexity tumors to 37.5% for patients with 
high complexity tumors (5). In a recent paper, Takahara 
et al. noted a lower rate of optimal surgical outcomes 
achievement in the high-complexity group (PADUA ≥10) 
of patients compared to non-high-complexity group (68.3% 
vs. 86.3%, respectively, P=0.009) (6).
Taking into account the three different outcomes 
included in MIC achievement between the groups of 
patients, in this analysis, the main cause of failure for 
optimal surgical outcomes was increased (>20 minutes) 
WIT. WIT was 21 (IQR: 18–27) minutes in patients with 
PADUA 12–13 compared to 17 (IQR: 14–21) minutes in 
patients with PADUA 10 (P<0.001), with more patients 
at highest complexity group having a WIT >20 min 
(39.7% vs. 15.7%, P=0.015, PADUA 12–13 vs. PADUA 
10, respectively). On the other hand, no significant 
difference was found between the groups of patients 
with lower and higher complexity tumors on PSMs and 
major complications (Clavien-Dindo >2) rates. WIT 
remains a topic of interest and debate in the literature, as 
the duration of ischemia is the only modifiable surgical 
factor affecting kidney function preservation, while the 
other factors are patient-depended and unmodifiable (age, 
preoperative renal function, comorbidities). A proposed 
acceptable time limit is 20–30 minutes, but most authors 
agree that it is not a binary outcome and that every minute 
counts during hilar clamping (7,8). Previous data, also, 
support the correlation between high PADUA score and 
increased WIT (9,10). The prolongation of ischemia 
duration seems a natural consequence during RAPN in 
complicated tumors as the reconstruction of the large 
collecting system and renal parenchyma defect have to 
be performed meticulously to avoid complications such 
hemorrhage and urine leakage.
We have to move beyond WIT analysis, studies support 
that prolonged WIT has a negative impact on functional 
outcomes, although they have focused mainly in the short-
term period (11). We support the idea that WIT has only a 
minor effect in long-term functional outcomes in patients 
with a normal contralateral kidney. The results of our series 
showed that neither WIT nor the method of clamping 
significantly affects the estimated glomerular filtration 
rate (eGFR) in a long-term period of follow-up (5,12). 
Even in cases of extreme WIT prolongation (30–60 min) 
there are data to support the mild structural changes on 
human kidney and the minimum effect on long-term 
functional outcomes (13,14). Authors choose to use the 
MIC achievement, which is a standardized system for 
reporting optimal surgical outcomes for NSS, to report 
and compare their results. However, this system does not 
include analysis of long-term functional outcomes and a 
separate analysis of how the difference in WIT between 
the groups of patients affected the long-term functional 
outcomes were not performed in this study. Recently, a 
new system of trifecta outcomes reporting for RAPN was 
published by Brassetti et al., which excludes WIT and 
includes postoperative eGFR reduction (15). This new 
reporting system could be more suitable for assessing 
RAPN outcomes in series where different techniques for 
hilar clamping are used, such as selective artery clamping 
or zero ischemia.
We must be grateful to authors for presenting the 
use of novel technologies, undoubtedly they are of great 
importance for assisting the surgeon to perform more 
complex cases. However, authors did not report the impact 
of the use of these techniques on perioperative outcomes 
and MIC achievement in this cohort. Also, always we 
have to bear in mind the economic impact for their use 
and difficulties adopting them in everyday practice. In 
our clinical practice, as in most institutions performing 
RAPN, the use of intraoperative laparoscopic ultrasound 
combined with TilePro technology is essential for almost 
every RAPN. Furthermore, we have previously described 
a simplified zero ischemia technique using kidney donor 
computed tomographic angiography, TilePro and 
conventional laparoscopic bulldog clamps, which is an easily 
adopted technique without special requirements (16). We 
believe that the use of novel technologies should be further 
assessed and validated in future prospective and ideally 
randomized studies, evaluating the oncological and the 
functional outcomes of RAPN.
The present study encounters some limitations. The 
retrospective nature of this study is a major drawback, 
albeit we have to admit that the inclusion of patients from 
different institutions increased the external validity of 
the study. The lack of definite inclusion criteria between 
different surgeons induced selection bias and the use of 
different surgical techniques and technologies during the 
period of study increase the heterogeneity, and authors have 
recognized it. The median follow-up period was relatively 
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short (28 months) for oncological outcomes reporting; this 
period of follow-up is adequate for long-term functional 
outcomes reporting, whereas authors did not include this 
outcome in the analysis.
RAPN is a feasible and effective treatment, when 
performed by experienced surgeons in accordance with the 
use of the novel technologies, even for the most challenging 
cases. However, in tumors with the highest complexity 
(PADUA 12–13), the surgical outcomes may be suboptimal 
and proper patient counseling should be given. In light of 
these promising results, there are indications that the high-
risk group suggested by PADUA classification seems to be 
not a single category. Further studies are needed to define 
the proper risk stratification and assessment of oncological 
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